Lastest from Businesswire

NEW YORK--(BUSINESS WIRE)--Saba Capital Income & Opportunities Fund II (NYSE: SABA) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, declared a monthly dividend of $0.058 per share on February 28, 2025, payable on March 31, 2025 to shareholders of record as of March 11, 2025. Managed Distribution Plan. The above distribution was declared in accordance with the Fund’s currently effective managed distribution plan (the “Plan”), whereby

LAS VEGAS--(BUSINESS WIRE)---- $GENI #antitrust--PANDA expands its lawsuit against Genius & Sportradar, alleging they illegally tie sports data access to their own betting tech, blocking competition

PERO, Italy--(BUSINESS WIRE)-- #Chemicals--Eigenmann & Veronelli (EV), Italy’s leading and internationally focused distributor of specialty chemicals and food ingredients, today announces that it has successfully completed the spin-off of its manufacturing operations to EV Produzione Srl. The newly incorporated company inherits a heritage of over 110 years of experience and marks a strategic turning point for the Group. Specializing in the manufacturing of chemical products for industry, with a consolid

MENLO PARK, Calif. & NEW YORK--(BUSINESS WIRE)--Silver Lake hereby announces that it will close its acquisition of Endeavor Group Holdings, Inc. (NYSE: EDR) on March 24, 2025 at $27.50 per share, subject only to closing conditions that Silver Lake is confident will be satisfied prior to such time. Almost one year ago, Silver Lake entered into a binding merger agreement at this price following extensive negotiations with a special committee of independent directors of the company and is confiden

NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced non-dilutive financings of up to $250 million with Sagard Healthcare Partners (Sagard). The transaction comprises a royalty interest financing of $150 million and a senior term loan of up to $100 million. These financings strengthen Nuvation Bio’s balance sheet to fully fund commercialization of taletrectinib in the U.S., if approve

LOS ANGELES & HONOLULU--(BUSINESS WIRE)--Hope Bancorp, Inc. (“Hope Bancorp”) (NASDAQ: HOPE), the holding company of Bank of Hope, and Territorial Bancorp Inc. (“Territorial”) (NASDAQ: TBNK), the holding company of Territorial Savings Bank, today jointly announced receipt of all required regulatory approvals to complete their previously announced merger (the “Merger”). Upon completion of the Merger, it is intended that the legacy Territorial franchise in Hawai‘i will operate under the trade name

NEW YORK--(BUSINESS WIRE)---- $SLXN #biotech--PESG Research releases a new market update on Silexion Therapeutics (NASDAQ: SLXN). Silexion recently announced the completion of its initial study evaluating SIL-204 in orthotopic pancreatic cancer models, a critical milestone that could continue to position its next-generation RNAi therapy at the forefront of KRAS-driven cancer treatment. With data analysis now underway and initial results expected in the coming weeks, according to the company’s latest announcement,

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Jabil Inc. (NYSE: JBL) has released its fiscal year 2024 Sustainability Progress Report, detailing the strides the company has made toward achieving its five-year sustainability goals. The report highlights Jabil’s substantial progress in reducing operational greenhouse gas emissions, diverting waste from landfills, and giving back to the communities where employees live and work. “As we navigate an era defined by complex global challenges, I am proud to r